HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feasibility of tomotherapy for Graves' ophthalmopathy: Dosimetry comparison with conventional radiotherapy.

AbstractPURPOSE:
To compare the dosimetry of tomotherapy and the conventional half-beam technique (HBT) or non-split beam technique (NSBT) for target coverage and radiation dose to the lacrimal glands and lens.
PATIENTS AND METHODS:
A retrospective review of 7 patients with Graves' ophthalmopathy who had radiotherapy because of disease progression on high steroid dose is reported: 3 patients were treated with tomotherapy and 4 patients with HBT.
RESULTS:
Compared to HBT, tomotherapy may provide better target coverage and significant reduction of radiation dose to the lacrimal glands and a higher dose to the lens. The NSBT improved target coverage but resulted in significantly higher doses to the lens and lacrimal glands.
CONCLUSION:
Tomotherapy may provide better coverage of the target volume and may be more effective in reducing severe exophthalmos compared to the conventional radiotherapy technique.
AuthorsNam P Nguyen, Shane P Krafft, Paul Vos, Vincent Vinh-Hung, Misty Ceizyk, Siyoung Jang, Anand Desai, Dave Abraham, Lars Ewell, Christopher Watchman, Russ Hamilton, Beng-Hoey Jo, Ulf Karlsson, Lexie Smith-Raymond
JournalStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (Strahlenther Onkol) Vol. 187 Issue 9 Pg. 568-74 (Sep 2011) ISSN: 1439-099X [Electronic] Germany
PMID21713392 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Prednisone
Topics
  • Adult
  • Anti-Inflammatory Agents (administration & dosage)
  • Drug Resistance
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Graves Ophthalmopathy (radiotherapy)
  • Humans
  • Middle Aged
  • Prednisone (administration & dosage)
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted
  • Radiotherapy, Intensity-Modulated (instrumentation)
  • Retrospective Studies
  • Tomography, Spiral Computed (instrumentation)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: